About Enhancer
| Enhancer ID: | E_01323 |
| Species: | Homo sapiens |
| Position : | chr11:69419632-69420080   |
| Year: | 2022 |
| Title: | The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | renal cell carcinoma |
| PMID: | 35676472 |
| MONDO: | MONDO:0005086 |
| Tissue: | Kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | 786-O |
| CVCL ID: | CVCL_1051 |
| Cell Type: | kidney cancer cell |
| Cell Ontology ID: | CL:0001066 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, ATAC-seq, RNA-seq |
| Low Throughput Method: | CRISPRi, Luciferase Reporter Assay, ChIP-RT-qPCR |
About Target Gene
| Target gene : | CCND1 |
About TF
| TF name : | PAX8 |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| PAX8 | ID | netpath | 38 |
| PAX8 | Pathways in cancer | kegg | 321 |
| PAX8 | Thyroid cancer | kegg | 25 |
| PAX8 | Hs_Thyroid_Stimulating_Hormone_(TSH)_signaling_pathway_WP2032_89823 | wikipathways | 28 |
Enhancer Associated Network
Overlapping Enhancers (hg38)
1 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01404 | chr11:69419632-69420080 | Bone | osteosarcoma cell | osteosarcoma |
Expression of Target Genes for the Enhancer